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ABSTRACT
In developing organisms, divergence from the canonical cell division
cycle is often necessary to ensure the proper growth, differentiation,
and physiological function of a variety of tissues. An important
example is endoreplication, in which endocycling cells alternate
between G and S phase without intervening mitosis or cytokinesis,
resulting in polyploidy. Although significantly different from the
canonical cell cycle, endocycles use regulatory pathways that also
function in diploid cells, particularly those involved in S phase entry
and progression. A key S phase regulator is the Cyclin E-Cdk2
kinase, which must alternate between periods of high (S phase) and
low (G phase) activity in order for endocycling cells to achieve
repeated rounds of S phase and polyploidy. The mechanisms that
drive these oscillations of Cyclin E-Cdk2 activity are not fully
understood. Here, we show that the Drosophila Cyclin E-Cdk2
inhibitor Dacapo (Dap) is targeted for destruction during S phase via a
PIP degron, contributing to oscillations of Dap protein accumulation
during both mitotic cycles and endocycles. Expression of a PIP
degron mutant Dap attenuates endocycle progression but does not
obviously affect proliferating diploid cells. A mathematical model
of the endocycle predicts that the rate of destruction of Dap during
S phase modulates the endocycle by regulating the length of
G phase. We propose from this model and our in vivo data that
endo S phase-coupled destruction of Dap reduces the threshold of
Cyclin E-Cdk2 activity necessary to trigger the subsequent G-S
transition, thereby influencing endocycle oscillation frequency and
the extent of polyploidy.
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INTRODUCTION
Developing organisms carefully regulate progression through the
cell cycle to ensure proper tissue growth and differentiation. Most
diploid cells proliferate by proceeding through the canonical
G1→S→G2→M cell cycle. However, the cell cycle is remarkably
malleable, and non-canonical cell cycles that omit gap phases,
mitosis, or cytokinesis occur frequently in both plants and animals
to support various developmental strategies and the biological
functions of particular cells and tissues (Vidwans and Su, 2001). An
important example is the endocycle, a cell cycle consisting of
alternating periods of G and S phase without mitosis or cytokinesis
resulting in polyploidy (Lee et al., 2009; Ullah et al., 2009b; De
Veylder et al., 2011; Fox and Duronio, 2013; Zielke et al., 2013).
Polyploid cells within otherwise diploid organisms (i.e.
endopolyploidy) are widespread in nature, and well-studied
examples include mammalian trophoblast giant cells, Arabidopsis
trichome cells, and the cells of Drosophila ovaries and salivary
glands. The biological purpose of endopolyploidy is poorly
understood and probably varies widely depending on tissue
function (Lee et al., 2009; Gentric and Desdouets, 2014).
Examples of this breadth of function include the regulation of cell
identity and differentiation (Hong et al., 2003; Raslova et al., 2007;
Bramsiepe et al., 2010), accommodating tissue growth without
disrupting epithelial integrity (Unhavaithaya and Orr-Weaver,
2012), and conferring resistance to DNA damage (Mehrotra et al.,
2008; Ullah et al., 2008). In addition, polyploidy is increasingly
implicated as a modulator of the development and progression of
cancer (Storchova and Pellman, 2004; Davoli and de Lange, 2011;
Fox and Duronio, 2013; Coward and Harding, 2014).
Endocycling cells utilize the same molecular toolkit as
proliferating diploid cells, including cyclin-dependent kinases
(CDKs), the transcriptional activator E2F, and the E3 ubiquitin
ligase complexes APC/C and CRL4Cdt2 (Lee et al., 2009; Ullah
et al., 2009b; De Veylder et al., 2011; Fox and Duronio, 2013;
Zielke et al., 2013). Nevertheless, the role and/or regulation of these
proteins can differ between canonical cycles and endocycles. For
example, whereas multiple distinct CDKs govern progression
through the canonical cell cycle, the endocycle is typically
controlled by a single S phase CDK, such as the well-studied
Drosophila Cyclin E-Cdk2 complex (Lilly and Duronio, 2005).
A universal feature of S phase control is that replication origin
licensing occurs only when CDK activity is low and origin firing
occurs only when CDK activity is high (Arias and Walter, 2007;
Diffley, 2011; Nordman and Orr-Weaver, 2012). Consequently,
alternating periods of low (i.e. G phase) and high (i.e. S phase)
Cyclin E-Cdk2 activity are required for repeated rounds of
endocycle S phase (Follette et al., 1998; Weiss et al., 1998). The
mechanisms that control oscillations of Cyclin E-Cdk2 activity in
the Drosophila endocycle operate at many levels, including those
that activate Cyclin E-Cdk2, such as the transcriptional induction of
the Cyclin E gene by E2f1 (Duronio and O’Farrell, 1995), and those
that inhibit Cyclin E-Cdk2, such as destruction of Cyclin E protein
by the SCFAgo E3 ubiquitin ligase (Moberg et al., 2001; Shcherbata
et al., 2004; Zielke et al., 2011). Therefore, in order to fully
understand the endocycle, all of the mechanisms that contribute to
oscillations of Cyclin E-Cdk2 activity must be determined. Here, weReceived 4 July 2014; Accepted 12 October 2015
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investigate the role of regulated proteolysis of the CDK inhibitor
(CKI) Dacapo (Dap) in the control of the Drosophila endocycle.
Dap is a member of the mammalian p21 family of CKIs and
functions as a specific inhibitor of Cyclin E-Cdk2, often to promote
exit from the cell cycle. In the embryonic epidermis, developing eye,
and nervous system transcriptional induction of the dap gene causes
rapid accumulation of Dap protein, resulting in inhibition of Cyclin
E-Cdk2 activity and contributing to G1 cell cycle arrest (de Nooij
et al., 1996; Lane et al., 1996; Firth and Baker, 2005; Buttitta et al.,
2007; Escudero and Freeman, 2007; Sukhanova and Du, 2008;
Colonques et al., 2011). However, in some tissues, Dap expression
does not induce cell cycle arrest. In particular, Dap expression
oscillates during endocycles of the polyploid nurse and follicle cells
of the ovary (Hong et al., 2003, 2007). The mechanisms that
generate these oscillations in expression are unknown, although cell
cycle-linked post-translational regulation Dap has been proposed
(Hong et al., 2003). Moreover, the functional role for oscillations of
Dap expression in the endocycle is unclear. Importantly, Dap is
required in both the nurse cells and follicle cells for normal
endocycle progression. Endo S phase is prolonged in dap mutants
(Hong et al., 2007), whereas Dap overexpression inhibits the
endocycle (Weiss et al., 1998; Shcherbata et al., 2004; Zielke et al.,
2011).
Here we show that Dap protein is destabilized during S phase by a
motif called the PIP degron, which has been shown in other proteins
to confer proteolysis via the CRL4Cdt2 E3 ubiquitin ligase, a key
regulator of both canonical cell cycles and endocycles (Abbas and
Dutta, 2011; Zielke et al., 2011). CRL4Cdt2 ubiquitylates substrates
containing a PIP degron only after the PIP degron directly interacts
with DNA-bound PCNA, the sliding clamp of the DNA replication
machinery (Havens and Walter, 2009). As a result, CRL4Cdt2
stimulates destruction of its substrates only when DNA is being
replicated and PCNA is loaded onto DNA, such as during S phase or
after DNA damage. CRL4Cdt2 substrates play crucial roles in
genome maintenance and include the replication licensing factor
CDT1, the mammalian CKI p21 (also known as CDKN1A), the
Set8 histone methyltransferase (also known as SETD8), and the
Drosophila E2f1 transcription factor (Havens and Walter, 2011).
We found that mutation of the PIP degron results in inappropriate
Dap accumulation during S phase, and that expression of a PIP-
degron mutant Dap protein disrupts the normal periodicity of the
endocycle, but does not affect proliferating cells or cell cycle exit.
An in silico model of the endocycle recapitulates our results and
suggests that endocycle frequency is directly influenced by the rate
of Dap destruction during S phase. We propose that S phase-
coupled Dap destruction is a common feature of the Drosophila
endocycle and promotes the development of multiple tissues by
modulating endocycle frequency.
RESULTS
DrosophilaDap contains a PIP degron necessary for S phase-
coupled destruction
Dap, like several of its homologs, contains a putative PIP degron
(Fig. 1A) (Havens and Walter, 2011). In addition, Dap protein
stability is regulated by Cul4 (Higa et al., 2006), a member of the
CRL4 complex. To determine if Dap is subject to S phase-coupled
destruction, we used our previously developed flow cytometry assay
to measure Dap accumulation during the cell cycle (Shibutani et al.,
2008; Davidson and Duronio, 2011). In this assay, a GFP-Dap
fusion protein is induced by a 30-min heat shock of S2 cells stably
transfected with an hsp70-GFP-dap construct, and DNA content of
the cell population is determined by flow cytometry at different
times after induction (Fig. 1B,C). In these populations, not all of the
cells express GFP-Dap, allowing us to determine in which phase of
the cell cycle GFP-Dap accumulates by comparing DNA content in
GFP+ cells to that of all the cells in the population. Two hours
following heat shock, GFP-Dap accumulated in cells in G1, S, and
G2. However, a smaller percentage of GFP+ cells had S phase DNA
content compared with the whole population (Fig. 1B,C). Because
the hsp70 promoter drives GFP-Dap transcription, and the mRNA
produced by these transgenes contains minimal 3′UTR sequences,
this difference most likely arises from S phase-specific post-
translational regulation rather than transcriptional or translational
controls. Moreover, GFP protein is stable in S phase cells (Shibutani
et al., 2008; Davidson and Duronio, 2012).
To test if the regulation of Dap protein accumulation involves the
PIP degron, we generated three different alanine-substitution
mutations that changed either all consensus PIP degron residues
(mDeg), only the residues predicted to contact PCNA (mPIP), or
only a lysine residue predicted to contact the Cdt2 subunit of
CRL4Cdt2 (mK+4) (Fig. 1A) (Havens and Walter, 2011). All three
PIP degron mutant proteins accumulated throughout the cell cycle
with no significant difference between the percentage of GFP+ cells
in S phase and the whole population (Fig. 1B,C). At four hours after
induction of GFP-DapmDeg expression, we observed an increase in
the number of G1 cells in the GFP+ population relative to the whole
population, as predicted by inhibition of Cyclin E-Cdk2 activity
(Fig. S1A). This result suggests that the mDeg mutation did not
disrupt the CDK inhibitory function of Dap. We did not perform a
similar experiment with the other two PIP degron mutant alleles, as
they each change only a subset of the residues mutated in the mDeg
allele and therefore will probably also retain CKI function. We
conclude from these data that the Drosophila Dap protein is subject
to PIP degron-dependent, S phase-coupled destruction.
To examine S phase stability of Dap in vivo, we stained BrdU-
labeled embryos with anti-Dap antibodies and observed that
the endogenous Dap protein did not accumulate to high levels
in S phase nuclei (Fig. 1D). While this observation is consistent
with S phase-coupled destruction of the Dap protein, it could
also reflect cell cycle-specific transcriptional regulation of Dap
expression. Therefore, we also used the GAL4/UAS system to
express GFP-Dap or GFP-DapmDeg transgenes under the control of a
UASp promoter, which would bypass any cell cycle-specific
transcriptional regulation of the endogenous gene. When expressed
ubiquitously using a tub-GAL4 driver, GFP-Dap levels were much
lower in replicating nuclei compared with nuclei that were not
replicating or replicating nuclei expressing only GFP (Fig. 1E,F,H;
Fig. S1B). By contrast, GFP-DapmDeg accumulated in BrdU-positive
nuclei (Fig. 1G,H; Fig. S1B). GFP-DapmDeg was significantly more
stable in replicating nuclei than GFP-Dap, indicating that mutation
of the PIP degron stabilized the GFP-DapmDeg protein in S phase.
We conclude from these data that the PIP degron of Dap contributes
to S phase-coupled destruction.
S phase stabilization of Dap does not disrupt mitotic cell
cycles
We next investigated the in vivo function of PIP-degron regulation
of Dap by comparing the developmental and cell cycle phenotypes
after expression of wild-type and PIP degron mutant GFP-Dap
proteins. During gastrulation, Drosophila embryonic epidermal
cells perform three cell division cycles before arresting in G1 of the
seventeenth cell cycle. Induction of zygotic Dap transcription
during interphase of cycle 16 is required for this cell cycle arrest (de
Nooij et al., 1996; Lane et al., 1996). We hypothesized that PIP
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degron-mediated destruction during S phase of cycle 16 might
function to prevent premature accumulation of Dap and precocious
cell cycle arrest. In contrast to our expectations, embryonic
epidermal cells expressing S phase-stabilized GFP-DapmDeg
progress normally through S phase of cell cycle 16, as do cells
expressing either GFP or GFP-Dap (Fig. 2A-C). After germ band
retraction, cells expressing GFP-Dap or GFP-DapmDeg under the
control of prd-GAL4 are similar in size to neighboring control cells
that do not express these proteins, indicating that they have
undergone the same number of cell divisions and arrest normally in
G1 of cycle 17 (Fig. 2D,E). These results differ from previously
published experiments in which overexpression of Dap in the
embryonic epidermis using a UASt-Dap transgene induces
premature cell cycle arrest (Lane et al., 1996). We suspected that
this discrepancy results from the UASt promoter driving higher
levels of expression than our UASp-Dap transgenes. We confirmed
this suspicion by western blotting of embryo extracts (Fig. S2A),
and also replicated the Lane et al. (1996) data using a UASt-Dap
Fig. 1. Dap contains a PIP degron that mediates S
phase-coupled destruction. (A) Alignment of human (Hs)
p21, Xenopus (Xl) Xic1, C. elegans (Ce) CKI-1, and Dap
PIP degrons. PCNA- andCdt2-binding residues highlighted
in red; consensus PIP degron at top. The alanine
substitution mutations in the Dap PIP degron are italicized.
(B,C) Flow cytometry of hsp70-GFP-Dap cells analyzed 2 h
after 30-min heat shock. (B) The percentage of GFP-
positive cells in S phase (green bars) is plotted with the
percentage of cells in the total population in S phase (white
bars; includes GFP-positive and GFP-negative cells).
Error bars indicate standard deviation (s.d.), *P<0.05.
(C) Representative cell cycle profiles with solid traces
indicating the total cell population and green traces
indicating GFP-positive cells. (D) 7-h-old wild-type embryo
stained with anti-Dap antibodies (green) and BrdU (red).
White arrows indicate a BrdU-negative cell with high Dap
expression, red arrows indicate a BrdU-positive cell with low
Dap expression. White box outlines area shown in higher
magnification. (E-G) 5-h-old embryos expressing GFP,
GFP-Dap, or GFP-DapmDeg using tub-Gal4 and stained
with anti-GFP antibodies (green) and BrdU (red). Yellow
arrows in E,G indicate GFP-positive cells that are also BrdU
positive, white and red arrows in F as in D. Note that GFP-
DapmDeg accumulates in cells undergoing S phase (G).
(H) Quantification of GFP fluorescence in BrdU-negative
(left) and BrdU-postive (right) cells from 5-h-old tub>GFP-
Dap and tub>GFP-DapmDeg embryos. Each point
represents a single cell; three embryos per genotype were
used for quantification. Middle bars represent mean; error
bars indicate s.d.; ns, not significant; ****P<0.00005.
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transgene (Fig. S2B,C). We also found no overt differences in either
the proliferation or differentiation of cells in the central and
peripheral nervous systems in embryos ubiquitously expressing
either GFP-Dap or GFP-DapmDeg (Fig. S3). Finally, expression of
the wild-type or S phase-stabilized Dap using engrailed-GAL4 did
not disrupt growth or proliferation in the posterior compartment of
third instar larvae wing imaginal discs (Fig. S4). We conclude that
the increase in Dap protein accumulation during S phase resulting
from mutation of the PIP degron is insufficient to significantly
disrupt cell cycle progression or exit in these tissues.
Expression of DapmDeg disrupts the pattern of endocycle
S phase in the embryonic midgut
Although S phase-coupled destruction of Dap did not overtly affect
the mitotically active tissues we examined, we found that tub>GFP-
DapmDeg progeny do not survive to adulthood. Approximately 90%
of tub>GFP-DapmDeg embryos fail to hatch, unlike tub>GFP-Dap
embryos, which hatch at normal rates and survive to adulthood. To
determine whether GFP-DapmDeg expression affected cell cycle
progression, we performed BrdU labeling of tub>GFP-DapmDeg
embryos, where we observed a phenotype in the developing
alimentary tract. The cells of the midgut and hindgut normally
become polyploid and begin endocycling in Stage 13 of
embryogenesis. In Stage 13 tub>GFP control embryos, cells
throughout the anterior and posterior midgut enter the first
endocycle S phase simultaneously (Fig. 3A). Midgut BrdU
incorporation in Stage 13 tub>GFP-Dap embryos is similar to
controls (Fig. 3B,D). By contrast, BrdU incorporation is scattered
irregularly in the midgut of Stage 13 tub>GFP-DapmDeg embryos
(Fig. 3C). Quantification of this phenotype revealed a reduced
midgut S phase index without a change in the number of midgut
cells (Fig. 3D,E), suggesting an endocycle defect rather than an
earlier arrest of cell proliferation.
S phase-coupled destruction of Dap can modulate normal
endocycle progression
To further investigate whether S phase-coupled destruction of Dap
has a role in endocycling tissues, we examined follicle cells of
the developing ovary because previous studies reported that Dap
expression fluctuates in these cells and that Dap function is required
for normal follicle cell endocycles (Hong et al., 2003, 2007). We
suspected that PIP degron-mediated destruction might contribute to
both the observed fluctuations in Dap protein accumulation and
normal endocycle progression within the follicle cells.
We tested this hypothesis by expressing our Dap transgenes in
endocycling follicle cells using the c323-GAL4 driver, which
activates follicle cell-specific expression beginning in Stage 8 egg
chambers (Manseau et al., 1997). Whereas GFP accumulated
uniformly in all follicle cells at Stage 9 (Fig. 4A), GFP-Dap
accumulated only in non-replicating cells (Fig. 4B,D,F; Fig. S1C).
In contrast to GFP-Dap, GFP-DapmDeg accumulated in both EdU-
positive and EdU-negative follicle cells (Fig. 4C,E,F; Fig. S1C).
GFP-DapmDeg was significantly more stable in EdU-positive cells
than GFP-Dap, indicating that PIP-degron-mediated S phase
destruction contributes to oscillating levels of Dap expression in
endocycling follicle cells (Fig. 4F). Interestingly, unlike GFP, GFP-
DapmDeg accumulation was not uniform: some follicle cells with
significant EdU incorporation had low levels of GFP-DapmDeg
accumulation (Fig. 4E,F; Fig. S1C), suggesting an additional, PIP
degron-independent mode of Dap turnover that is itself linked to
Fig. 2. S phase-stabilized Dap expression does not disrupt the
embryonic epidermal cell cycle program. (A-C) 6-h-old embryos
expressing GFP (A) or GFP-Dap (B,C) transgenes with tub-Gal4
and stained for GFP (green) and BrdU (red). Epidermal cells in all
three genotypes enter and progress normally through S phase of
cell cycle 16 (S16). (D,E) Germ band-retracted embryos expressing
GFP (D) or Dap (E) transgenes with prd-Gal4 and stained with anti-
GFP (green) and anti-Dlg (red) antibodies to mark the cell cortex to
indicate cell size. White boxes outline area shown in higher
magnification.
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either replication or Cyclin E-Cdk2 activity during S phase (see
Discussion). We also noted that GFP-DapmDeg accumulated to
greater levels than GFP-Dap outside of S phase as well; because
these transgenes are under the same transcriptional controls,
differences in expression must arise from differences in PIP
degron-regulated protein stability and/or resulting changes to the
endocycle (i.e. prolonged G phase or arrest) (Fig. 4F, Fig. S1C).
We assessed the effect of Dap transgene expression on endocycle
progression by calculating the percentage of follicle cells
undergoing S phase in Stage 9 egg chambers by EdU labeling.
We found that an average of 38% of GFP-expressing control follicle
cells were in S phase at this stage (Fig. 4G). Expression of GFP-Dap
resulted in a small but statistically significant decrease in the number
of S phase cells (27%) (Fig. 4G). Expression of GFP-DapmDeg,
however, resulted in a sharp decline in the percentage of follicle
cells undergoing S phase (11%) (Fig. 4G). Thus, expression of wild-
type Dap, which is rapidly destroyed during S phase, is well
tolerated by follicle cells, whereas expression of a version of Dap
that is less efficiently destroyed during S phase impairs endocycle
progression. Follicle cells perform 3 endocycles over a 24-h period
between Stages 7 and 9 (Calvi et al., 1998). Thus, between Stages 8
and 9 only one to two endocycles occur, suggesting that follicle cell
endocycle disruption occurs relatively soon after GFP-DapmDeg
expression.
To extend these observations, we examined the highly polyploid
Drosophila salivary gland cells, which are frequently used as a
paradigm to dissect mechanisms of endocycle progression. Previous
work showed that Dap is not absolutely required for salivary gland
endocycles, but that the average size and DNA content of dap
mutant salivary glands is slightly reduced relative to wild type
(Zielke et al., 2011). We detected low levels of endogenous Dap
protein in salivary glands that oscillate in a pattern reminiscent of
that in the follicle cells: Dap accumulation is highest in G phase
nuclei and lowest or absent in replicating nuclei (Fig. 5A). Using the
ptc>GAL4 driver, we found that GFP-Dap is absent from cells
undergoing S phase and highest in cells that are not replicating
(Fig. 5C,E,H; Fig. S1D). We also detected cells that were not
replicating and lacked GFP-Dap (Fig. 5C,E), perhaps representing
cells that have stopped endocycling. By contrast, DapmDeg is
significantly more stable in S phase nuclei than Dap (Fig. 5D,F,H;
Fig. S1D). As in follicle cells, the stabilization of DapmDeg was not
uniform in all EdU-positive cells in the salivary gland, suggesting
that PIP-degron-independent mechanisms also control Dap stability
in these cells (Fig. 5D,F,H; Fig. S1D).
As before, we assessed endocycle progression by calculating
the percentage of cells undergoing S phase after Dap expression.
While expression of GFP-Dap did not significantly alter the
percentage of S phase cells in the salivary gland compared with
GFP-only controls (33% vs 42%, respectively), expression
of DapmDeg resulted in a dramatic decline in the percentage of
S phase cells (7%) (Fig. 5I). Furthermore, nuclear size and
DAPI intensity were significantly lower in glands expressing
DapmDeg (Fig. 5J,K), indicating a reduction in endocycle
frequency that prevents cells from reaching normal ploidy.
Western blotting indicated that GFP-Dap and GFP-DapmDeg
were overexpressed in salivary glands to similar levels (Fig. 5G).
Thus, although Dap is not required for the salivary gland
endocycle to proceed, we propose that PIP-degron-mediated
regulation of Dap accumulation in this tissue might contribute to
normal endocycle progression.
Mathematical modeling predicts that S phase-coupled Dap
destruction modulates endocycle oscillations
Our data indicate that Dap undergoes S phase-coupled destruction
in multiple tissues. Whereas expression of wild-type Dap using
UASp is well tolerated by the cell types we examined, a decline in
cells undergoing endo S phase results when DapmDeg is expressed
(Fig. 3D, Fig. 4G, Fig. 5I). This phenotype suggests that the
endocycle is particularly sensitive to changes in S phase-coupled
destruction of Dap. One possible explanation for these results is that
a failure to fully destroy Dap during S phase might increase the
amount of Cyclin E-Cdk2 needed to trigger the G-S transition in the
subsequent endocycle. If true, then the amount of time required to
achieve the critical level of Cyclin E-Cdk2 activity might also
Fig. 3. S phase-stabilized Dap expression disrupts endocycle
progression in the embryonic gut. (A-C) Stage 13 embryos
expressing GFP (A) or GFP-Dap (B,C) transgenes with tub-Gal4
and stained for GFP (green) and BrdU (red). The first endocycle
S phase in the anterior midgut (amg) and posterior midgut (pmg)
normally occurs concurrently. (D) Quantification of percentage of
anterior midgut cells undergoing S phase in Stage 13 embryos.
(E) Relative cell density in the anterior midguts of Stage 13
embryos. Each dot represents one embryo.Middle bars represent
mean; error bars indicate s.d.; ns, not significant; *P<0.05;
**P<0.005.
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increase, resulting in a reduction of endocycle oscillation frequency.
We tested this hypothesis using a previously described
mathematical model of the Drosophila endocycle (Zielke et al.,
2011). This original model did not include any input from Dap
protein. Based on our results, we modified the model to incorporate
both Dap expression and S phase-coupled Dap destruction
(Fig. 6A). We reasoned that this new model would more
accurately reflect the Drosophila endocycle program and provide
insight into how changing the rate of Dap destruction during S phase
would affect endocycle oscillation.
The new model incorporates three key regulatory relationships
between Dap and Cyclin E-Cdk2 activity: (i) transcriptional
activation of Dap by Cyclin E, described previously (de Nooij
et al., 2000); (ii) direct inhibition of Cyclin E-Cdk2 activity by Dap;
and (iii) destruction of Dap triggered by CRL4Cdt2 after Cyclin E
synthesis promotes S phase entry (Fig. 6A). Also, we used model
rate parameters that recapitulated the subtle changes in endocycle
frequency observed in dap mutants (Zielke et al., 2011) (Table S1).
We examined several scenarios with this model. First, the addition
of Dap to the original model (Fig. 6B) reduces the frequency of
Cyclin E oscillations by lengthening G phase (i.e. E2F spike
duration), thereby altering endocycle periodicity (Fig. 6C). Second,
removal of S phase-coupled destruction (i.e. CRL4 in the model) of
endogenous Dap results in the elimination of endocycle oscillations
(Fig. 6D).
We next modeled our transgenic system of exogenous,
continuously expressed Dap. At low levels of expression,
exogenous Dap affects the periodicity of the endocycle by slightly
decreasing the frequency of Cyclin E oscillations and slightly
increasing G phase length (Fig. 6E compared with 6C). This change
is consistent with our in vivo observation thatUASp-Dap expression
reduces the number of S phase follicle cells even with PIP-degron
regulation intact (Fig. 4F). Further increasing the level of exogenous
Dap expression further diminishes the oscillation frequency of
the endocycle (Fig. 6G). When S phase-coupled destruction of
exogenous Dap is eliminated there is a rapid cessation of endocycle
oscillations (Fig. 6F,H), consistent with our in vivo observations in
both follicle cells and salivary glands that DapmDeg expression
reduces the number of cells in S phase. Finally, because we noted
that mutation of the PIP degron did not completely stabilize Dap
during S phase in the follicle cells and salivary glands, we modeled
incomplete degradation of endogenous Dap to examine how
CRL4Cdt2 might function cooperatively with other mechanisms to
regulate Dap stability and endocycle progression. Strikingly, even a
modest reduction in the rate of Dap destruction doubles the length of
G phase (Fig. 6I). In fact, in our model, partial stabilization of
endogenous Dap has a more dramatic effect on the endocycle than
overexpression of a version of Dap that is still subject to S phase
destruction (Fig. 6E,I). Thus, mathematical modeling supports our
in vivo observations that the endocycle is sensitive to expression of a
Fig. 4. S phase-stabilized Dap expression disrupts endocycle progression in ovarian follicle cells. (A-C) Stage 9 egg chambers expressing GFP (A) or
GFP-Dap (B,C) transgenes with c323-GAL4 and stained for GFP (green), EdU (red), and DAPI (blue). (D,E) Higher magnification views (white boxes in B and
C, respectively) of EdU-negative nuclei with high GFP-Dap or GFP-DapmDeg (white arrows), an EdU-positive nucleus with low GFP-Dap expression (red arrows),
and EdU-positive nuclei with different amounts of GFP-DapmDeg (yellow arrows/arrowheads). Nuclei with extensive EdU incorporation (yellow arrow) typically
had less GFP-DapmDeg than nuclei with more modest EdU incorporation (yellow arrowhead). (F) Quantification of GFP fluorescence in EdU-negative (left) and
EdU-postive (right) cells from Stage 10 ovarian follicle cells. Each point represents a single cell; three egg chambers per genotype were used for quantification.
(G) Quantification of the percentage of follicle cells undergoing S phase in Stage 10 egg chambers. Each dot represents one egg chamber. Middle bars represent
mean; error bars indicate s.d.; *P<0.05; ****P<0.00005.
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PIP-degron mutant Dap and suggests that S phase-coupled
destruction of Dap modulates endocycle progression.
DISCUSSION
In this study we show that the Cyclin E-Cdk2 inhibitor Dap contains
a PIP degron that confers destruction of Dap protein during S phase
in multiple tissues during Drosophila development. Thus far, all
proteins with a functional PIP degron are substrates of CRL4Cdt2,
making it highly probable that Dap destruction is mediated by the
CRL4Cdt2 E3 ubiquitin ligase. CRL4Cdt2 regulation of the Cip/Kip
family of CKIs is highly conserved: Xenopus Xic1 (also known as
Cdknx), C. elegans CKI-1, and human p21 all are targets of
Fig. 5. S phase-stabilized Dap expression disrupts
endocycle progression in salivary glands. (A) Wild-type
third instar larval salivary gland stained with anti-Dap
antibodies (green), DAPI (blue) and EdU (red). White box
outlines the higher magnification region showing an EdU-
negative, G phase nucleus with high levels of Dap (white
arrow), an extensively labeled S phase nucleus with no Dap
(red arrow), and an S phase nucleus with a low level of Dap
protein that does not overlap with the EdU signal (yellow
arrow). (B-D) Early third instar larval salivary glands
expressing GFP (B) or GFP-Dap transgenes (C,D) with ptc-
GAL4 and stained for GFP (green), DAPI (blue) and EdU
(red). fb, fat body. (E,F) Higher magnification images of
ptc>GFP-Dap and ptc>DapmDeg salivary glands (white
boxes in right panels of C,D) showing EdU-negative nuclei
with high GFP-Dap or GFP-DapmDeg (white arrows), an EdU-
positive nucleus with very low or no GFP-Dap (red arrow),
and an EdU-positive nucleus with highGFP-DapmDeg (yellow
arrow). (G) Immunoblot of equal numbers of salivary glands
of the indicated genotypes using anti-GFP antibodies to
detect GFP-Dap. Anti-lamin is a loading control.
(H) Quantification of GFP fluorescence in EdU-negative (left)
and EdU-postive (right) cells from salivary glands. Each point
represents a single cell; three glands per genotype were
used for quantification. (I-K) Quantification of the S phase
index (I), nuclear size (J), and DAPI intensity (K) in salivary
glands expressing GFP or GFP-Dap transgenes. In J and K
ptc>GFP-Dap and ptc>GFP-DapmDeg measurements were
normalized to the average nuclear size and DAPI intensity in
ptc>GFP glands, respectively. Middle bars indicate the
mean; error bars indicate s.d.; ns, not significant;
***P<0.0005; ****P<0.00005.
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CRL4Cdt2 (Abbas et al., 2008; Kim et al., 2008, 2010; Nishitani
et al., 2008). Yet relatively little is known about the in vivo
developmental function of CRL4Cdt2-mediated destruction of CKIs.
In studies of cul-4 and cdt-2 RNAi-treated C. elegans, S phase
stabilization of CKI-1 inhibited nuclear export of the replication
licensing factor CDC-6 and contributed to re-replication, a function
that appears to be conserved for mammalian p21 (Kim et al., 2007,
2008). Interpreting phenotypes resulting from CRL4Cdt2 depletion
is complicated because CRL4Cdt2 has multiple substrates, including
those such as Cdt1 that function in DNA replication (Hu et al., 2004;
Arias and Walter, 2006; Hu and Xiong, 2006; Senga et al., 2006).
By mutating the PIP degron, we altered Dap stability without
interfering with the regulation of other CRL4Cdt2 substrates. Using
this strategy, we found that expressing a PIP-degron mutant Dap
(DapmDeg) affects the Drosophila endocycle.
High-level overexpression of Dap was previously shown to
induce precocious cell cycle exit (de Nooij et al., 1996; Lane et al.,
1996). We were therefore initially surprised that expression of the
DapmDeg mutant protein had no apparent effect on mitotic cycles in
either the embryonic epidermis or wing imaginal disc. We could
reproduce the precocious cell cycle arrest reported by Lane et al.
(1996) using aUASt-Dap transgene, and our UASp transgenes were
expressed at a lower level than with the UASt promoter. Thus, the
level of Dap accumulation attained in our experiments reveals a
difference between mitotic and endocycling cells. Such differences
have been noted before. For example, Cyclin E expression is higher
in mitotically dividing cells of the embryonic central nervous
system than it is in endocycling cells (Richardson et al., 1993;
Knoblich et al., 1994), probably as a result of E2f1-independent
expression ofCyclin E (Duronio and O’Farrell, 1995). Thus, mitotic
cycles might have higher Cyclin E-Cdk2 activity than endocycles,
and as a result endocycles might be more sensitive to levels of Dap
expression and thus require additional modes of Dap regulation. As
with Dap, bypassing PIP degron-mediated destruction of E2f1 does
not cause arrest of mitotically dividing cells, and S phase-coupled
destruction of E2f1 plays an important role in the endocycle by
helping generate oscillations of Cyclin E transcription (Shibutani
et al., 2008; Zielke et al., 2011; Davidson and Duronio, 2012).
We make interpretations regarding the function of S phase-
coupled Dap destruction in those tissues where Dap expression and
DapmDeg expression have different effects. In this regard, our data
provide evidence that S phase-coupled destruction of Dap has a
modulatory role in endocycling cells, even in tissues such as the
salivary gland where removal of Dap function does not prevent
endocycle progression (Zielke et al., 2011). However, we note that
our experiments do not directly address the role of PIP degron-
mediated destruction of endogenous Dap. Addition of Dap to a
mathematical model of the endocycle alters endocycle frequency,
primarily by increasing the length between peaks of Cyclin E-Cdk2
activity, which we infer as a measure of G phase length. The
model’s predictions correspond with our results as well as previous
data from ovarian follicle cells and nurse cells, where removal of
dap results in decreased length of G phase and leads to endocycle
defects (Hong et al., 2007). We propose that PIP degron-mediated
destruction of Dap plays a role in modulating endocycle periodicity
by depleting Dap protein during S phase, thereby lowering the
threshold needed for Cyclin E-Cdk2 to drive S phase entry.
S phase-coupled destruction represents just one facet of Dap
regulation in endocycling cells. Previous studies have shown that
dap transcription is regulated by Cyclin E (de Nooij et al., 2000).
Our data also suggest that PIP degron-mediated destruction is not
the only regulator of Dap stability during S phase. We observed
persistent fluctuations of DapmDeg protein accumulation that appear
to be linked to the cell cycle, as DapmDeg levels were highest in
G phase cells and tended to be lower in cells with the greatest levels
of EdU incorporation. Any additional mode of Dap regulation is
probably post-translational, as transgene transcription is controlled
by the same GAL4 drivers and the transgenes include only a
minimal 3′UTR. It has previously been shown that Dap protein
stability is regulated by the CRL1Skp2 ubiquitin ligase (also known
Fig. 6. Mathematical modeling of
the Drosophila endocycle.
(A) Network diagram of the molecular
interactions within an existing
endocycle model (Zielke et al., 2011).
Our additions to the previous model
are in bold. (B) The Zielke et al.,
(2011) endocycle model, which did
not include Dap, showing oscillation
of the levels or activity of key cell cycle
regulators. The x and y axes display
arbitrary units. (C) The revised
endocycle model including Dap
(orange curves). (D) Removal of
CRL4Cdt2 regulation of endogenous
Dap eliminates endocycle
oscillations. (E-H) Modeling
exogenousDap. Addition of wild-type,
exogenous Dap at either 1× (E) or 10×
(G) relative levels reduces endocycle
frequency. Removal of CRL4Cdt2
regulation of exogenous Dap at either
level of expression (F and H,
respectively) eliminates endocycle
oscillations. (I) Reduction of S phase
degradation of endogenous Dap
alters endocycle periodicity.
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as SCFSkp2) (Dui et al., 2013). CRL1Skp2 activity is linked to the cell
cycle, and mammalian p27 is targeted for destruction by CRL1Skp2
following phosphorylation by Cyclin E-Cdk2 (Carrano et al., 1999;
Sutterlüty et al., 1999; Tsvetkov et al., 1999; Nakayama and
Nakayama, 2005). However, our data suggest that CRL1Skp2
regulation of Dap might not be sufficient to control endocycle
progression in the absence of PIP degron-mediated destruction.
Multiple modes of regulation – PIP degron-dependent and
independent destruction, as well as transcriptional regulation of
dap by Cyclin E-Cdk2 – are probably required to cooperatively
fine-tune Dap protein expression during the endocycle.
Finally, S phase destruction of CKIs might be a general feature
of endocycle programs (Ullah et al., 2009a). CRL4Cdt2 regulation
of CKIs is required for trichome endocycles in Arabidopsis
(Roodbarkelari et al., 2010). Similarly, CRL1Skp2-mediated
depletion of p57 (also known as CDKN1C) during S phase in
endocycling trophoblast giant cells is crucial for endocycle
progression (Hattori et al., 2000). Therefore, it is possible that
some mode of S phase destruction of CKIs is a general feature of the
endocycle program in most organisms.
MATERIALS AND METHODS
Generation of Dap transgenes
Wild-type or mutagenized (Stratagene) dap open reading frames were
cloned into pENTR-d/TOPO (Invitrogen) before subcloning into either
pHGW (Drosophila Gateway Vector Collection) for stable transfection of
S2 cells (Davidson and Duronio, 2011) or a modified pPGW vector (a gift
from Steve Rogers) that includes an AttB site for phiC31-mediated
transgenesis.
Cell culture transfection, expression and analysis by flow
cytometry
S2 cells collected 2-4 h after a 30 min, 37°C heat shock or dissociated wing
disc samples were prepared for flow analysis as previously described
(Davidson and Duronio, 2011). GFP expression and DNA content were
measured using a Dako CyAn (S2 cells) or a Becton Dickinson LSR II (wing
discs) flow cytometer and ModFit (S2 cells) or FlowJo (wing discs)
software. Data from S2 analysis were analyzed for statistical significance
with a two-way ANOVA test.
Fly stocks
UASp-GFP-Dap transgenes inserted into AttP2 [Bloomington Drosophila
Stock Center (BDSC) #8622] were expressed using Tub-GAL4/TM3 (BDSC
#5138), Ptc-GAL4 (BDSC #2017), and c323-GAL4/CyO (Manseau et al.,
1997). UAS-GFP was obtained from the Bloomington Stock Center. UASt-
DapII.2 was kindly provided by Christian Lehner.
Western blotting
Dechorionated embryos or salivary glands were lysed by disruption
with a pestle in 2× lysis buffer (0.125M Tris pH 6.8, 1% SDS, 5% BME)
and cleared twice by centrifugation. Samples were run on 4-15% Mini-
PROTEAN TGX gels (BioRad), transferred to Immobilon-P PVDF
membranes (Millipore), stained with 0.1% Ponceau in 5% acetic acid for
2 min, and imaged on a UVP Biospectrum Imaging System. Antibodies
were: rabbit anti-Dap (1:1000; a gift fromChristianLehner),mouse anti-GFP
(1:2000; JL-8, Clontech), mouse anti-lamin (1:1000; ADL84.12, DSHB),
HRP-donkey anti-rabbit (1:30,000; catalog #NA934, GE Healthcare), and
HRP-sheep anti-mouse (1:30,000; catalog #NA931, GE Healthcare).
SuperSignal West Dura Chemiluminescent Substrate (Thermo) and Blue
Devil Premium film were used to detect HRP activity (Genesee).
BrdU labeling, EdU labeling and immunofluorescence
BrdU labeling of embryos was performed as previously described
(Sloan et al., 2012). For co-detection of S phase and Dap, embryos were
fixed for 15 min in 3.7% formaldehyde after antibody staining prior to
BrdU detection. Ovaries from 2- to 3-day-old females or third-instar
larval wing discs were dissected in Grace’s media, incubated for 1 h in
0.1 mg/ml EdU, and fixed for 20 min in 3.7% formaldehyde. EdU-
labeled ovaries were fixed for 10 min in 3.7% formaldehyde after
antibody staining, followed by EdU detection using the Click-iT EdU
AlexaFluor 488 Imaging Kit (Invitrogen). Salivary glands were dissected
from early third-instar larvae collected 96 h after egg deposition before
undergoing EdU labeling, staining and detection as described for ovaries.
Antibodies used were: rabbit anti-GFP (1:1000; catalog #ab290, Abcam),
mouse anti-BrdU (1:500; catalog #347580, BD Biosciences), mouse anti-
Dlg (1:1000; Hybridoma product number 4F3, DSHB), rat anti-Elav
(1:100; Hybridoma product number 7E8A10, DSHB), rabbit anti-Dap
(1:100, a gift from Christian Lehner), goat anti-rabbit AlexaFluor 488
(1:1000; catalog #A-11034, Invitrogen), and goat anti-mouse Cy3
(1:1000; catalog #115-165-003, Jackson Immunoresearch Laboratories).
Imaging was carried out using a Zeiss 700 or Zeiss 710 confocal
microscope and image processing was performed using Adobe
Photoshop. Quantification of fluorescence was performed by measuring
fluorescence intensity of single cells (delineated manually) using ImageJ
(National Institutes of Health).
Quantification of S phase cell populations, cell density and
salivary gland nuclear size
S phase was quantified in Stage 9 egg chambers in which follicle cell
migration had progressed between 3/4 to 2/3 the length of the egg
chamber. S phase percentage was calculated by counting all EdU-positive
follicle cell nuclei in a single confocal section for 13 egg chambers. We
similarly calculated the percentage of S phase cells in 18 salivary glands
of each genotype dissected 96 h after egg deposition. For embryonic S
phase analysis, we counted EdU-positive cell nuclei in single confocal
sections of the anterior midguts of five to six Stage 13 embryos per
genotype. We quantified cell density in the anterior midguts of five to six
embryos per genotype by counting DAPI-positive nuclei within a defined
region of a confocal section using ImageJ. Statistical significance was
determined using two-sided t-tests. Nuclear area and DNA content of
three DAPI-stained nuclei at the posterior end of five salivary glands
from each genotype were measured using ImageJ. Data were normalized
to the average nuclear area and average DAPI intensity of ptc>GFP
nuclei and analyzed used two-sided t-tests. For DNA content the average
cytoplasmic integrated density was subtracted from each measurement to
control for background.
Mathematical modeling
We extended and revised the endocycle model of Zielke et al., (2011) to
enhance the rate of Cyclin E deactivation through the addition of a Cyclin E-
Dap-Cyclin E negative feedback loop (Fig. 6A). The revised model includes
Cyclin E activation of Dap transcription (de Nooij et al., 2000), Dap
inhibition of Cyclin E-Cdk2 activity, and CRL4Cdt2 enhancement of Dap
destruction. Using the previously described model convention, we defined























where the first two terms on the right hand side of Eqn 1 account for
exogenous and Cyclin E-dependent Dap expression, respectively, and the
second two terms account for Cul4-dependent and basal Dap degradation,
respectively. We modified the previously defined equation for Cyclin E
levels (Equation 10 of Zielke et al., 2011) to include Dap-dependent
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where the first term in Eqn 2 represents the synthesis of Cyclin E as a
function of the previously defined delay cycle (Zielke et al., 2011), and the
second and third terms define the rate of Dap induced and basal inhibition of
Cyclin E, respectively. Starting from the values reported by Zielke et al.
(2011), we performed a brute force parameter search to identify an
appropriate set of model rate parameters such that the addition of
endogenous Dap did not significantly alter the amplitude of Cyclin E
from the previously established endocycle model (Table S1). Furthermore,
we required that the removal of Dap mimic previously established dap
mutant data (Zielke et al., 2011). We used the E2F spike duration as a proxy
for G phase and the square pulse duration of the CRL4Cdt2 as a proxy for the
duration of S phase. Dap (1×) increased the duration of G phase by ∼1.2
times the length of G phase for the Dap-deficient mutant. For each
subsequent multiplicative Dap addition (2×-10×) the length of G phase
increased in proportion to 1.2× the previous G phase length.
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